BMJ 1998;317:613-614 ( 5 September )

Editorials

Control of antimicrobial resistance: time for action

The essentials of control are already well known 

The first 150 words of the full text of this article appear below.

Until recently the medical community world wide has seemed incapable of reacting to the imminent crisis of antibiotic resistance. Several explanations exist for this lack of action, including the complex interaction between doctors, patients, and parents over antibiotic use ^{1 2} and the fact that the pharmaceutical industry has so far succeeded in developing new antibiotics when resistance to existing ones has emerged. Although we still need a better understanding of the factors involved in the emergence and spread of antibiotic resistance, action cannot wait until all the answers are available. The essentials of better control of antibiotic resistance are already well known.

Surveillance of bacterial resistance is a key element in understanding the size of the problem. The large number of existing networks for resistance surveillance need to be coordinated and the results made available.³ To help doctors choose appropriate antibiotics and to detect local epidemics of resistant bacteria surveillance at . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Meeting the challenge of antibiotic resistance

Otto Cars, Liselotte Diaz Högberg, Mary Murray, Olle Nordberg, Satya Sivaraman, Cecilia Stålsby Lundborg, Anthony D So, and Göran Tomson
BMJ 2008 337: a1438. [Extract] [Full Text]

This article has been cited by other articles:

• White, A. R., on behalf of the BSAC Working Parties on Resistanc, (2008). The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative model. J Antimicrob Chemother 62: ii3-ii14 [Abstract] [Full text]  
• Cars, O., Hogberg, L. D., Murray, M., Nordberg, O., Sivaraman, S., Lundborg, C. S., So, A. D, Tomson, G. (2008). Meeting the challenge of antibiotic resistance. BMJ 337: a1438-a1438 [Full text]  
• Varonen, H., Rautakorpi, U.-M., Nyberg, S., Honkanen, P. O, Klaukka, T., Palva, E., Roine, R., Sarkkinen, H., Makela, M., Huovinen, P., for the MIKSTRA Collaborative Study Group, (2007). Implementing guidelines on acute maxillary sinusitis in general practice--a randomized controlled trial. Fam Pract 24: 201-206 [Abstract] [Full text]  
• Coenen, S., Van Royen, P., Michiels, B., Denekens, J. (2004). Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J Antimicrob Chemother 54: 661-672 [Abstract] [Full text]  
• Garcia-Rey, C., Fenoll, A., Aguilar, L., Casal, J. (2004). Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain. J Antimicrob Chemother 54: 465-471 [Abstract] [Full text]  
• Franz, A. R., Bauer, K., Schalk, A., Garland, S. M., Bowman, E. D., Rex, K., Nyholm, C., Norman, M., Bougatef, A., Kron, M., Mihatsch, W. A., Pohlandt, F., for the International IL-8 Study Group, (2004). Measurement of Interleukin 8 in Combination With C-Reactive Protein Reduced Unnecessary Antibiotic Therapy in Newborn Infants: A Multicenter, Randomized, Controlled Trial. Pediatrics 114: 1-8 [Abstract] [Full text]  
• Brooks, N., Darmnng, F., Bell, I., Charles, J. (2003). An evaluation of nurses' record-keeping skills and knowledge of using patient group directions for antibiotics at a walk-in centre. Journal of Research in Nursing 8: 440-452 [Abstract]  
• Kahlmeter, G., Brown, D. F. J. (2002). Resistance surveillance studies--comparability of results and quality assurance of methods. J Antimicrob Chemother 50: 775-777 [Full text]  
• Macmillan, S. (2002). Chlamydia trachomatis in subfertile women undergoing uterine instrumentation: The clinician's role. Hum Reprod 17: 1433-1436 [Abstract] [Full text]  
• Hunter, P. A., Reeves, D. S. (2002). The current status of surveillance of resistance to antimicrobial agents: report on a meeting. J Antimicrob Chemother 49: 17-23 [Abstract] [Full text]  
• Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., The Spanish Surveillance Group for Respiratory Pat, (2001). Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain. Antimicrob. Agents Chemother. 45: 3334-3340 [Abstract] [Full text]  
• Priest, P., Yudkin, P., McNulty, C., Mant, D., Wise, R. (2001). Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study Commentary: antibiotic resistance is a dynamic process. BMJ 323: 1037-1041 [Abstract] [Full text]  
• Huovinen, P. (2001). Bacteriotherapy: the time has come. BMJ 323: 353-354 [Full text]  
• Cookson, B. (2000). Infection and antimicrobial prescribing control in the new millennium: nightmare or nirvana?. J. Clin. Pathol. 53: 66-70 [Full text]  
• Nathwani, D., Davey, P. (1999). Antibiotic prescribing—are there lessons for physicians?. QJM 92: 287-292 [Full text]  
• Smith, S., Tilton, R. C. (1999). Antibiotic Resistance: the Bermuda Experience. J. Clin. Microbiol. 37: 1231-1232 [Full text]  

Online poll

Find out more >>